Diseases & Conditions market research reports by DelveInsight

• HER2 Negative Breast Cancer- Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  HER2 Negative Breast Cancer- Pipeline Insight, 2024 DelveInsight’s, “HER2 Negative Breast Cancer- Pipeline Insight, 2024” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in HER2 Negative Breast Cancer pipeline landscape. It covers the pipeline drug profiles, includi ... Read More

• Celiac Disease- Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Celiac Disease- Pipeline Insight, 2024 DelveInsight’s, “Celiac Disease- Pipeline Insight, 2024,” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Celiac Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage prod ... Read More

• Unresectable Melanoma - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Unresectable Melanoma - Pipeline Insight, 2024 Unresectable Melanoma Overview ""Unresectable Melanoma Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Unresectable Melanoma market. A detailed pictu ... Read More

• Hemophilia A - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Hemophilia A - Pipeline Insight, 2024 DelveInsight’s, “Hemophilia A - Pipeline Insight, 2024” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Hemophilia A pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products ... Read More

• Genital Herpes - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Genital Herpes - Pipeline Insight, 2024 DelveInsight’s, “Genital Herpes - Pipeline Insight, 2024,” report provides comprehensive insights about 26+ companies and 28+ pipeline drugs in Genital Herpes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage p ... Read More

• Acute Lymphoblastic Leukemia (ALL) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Acute Lymphoblastic Leukemia (ALL) - Pipeline Insight, 2024 Acute Lymphoblastic Leukemia (ALL) Overview ""Acute Lymphoblastic Leukemia (ALL) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute L ... Read More

• Autoimmune Gastritis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Autoimmune Gastritis - Pipeline Insight, 2024 Autoimmune Gastritis Overview ""Autoimmune Gastritis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Autoimmune Gastritis market. A detailed picture o ... Read More

• Autoimmune Hepatitis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Autoimmune Hepatitis - Pipeline Insight, 2024 DelveInsight’s, “Autoimmune Hepatitis - Pipeline Insight, 2024,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Autoimmune Hepatitis pipeline landscape. It covers the pipeline drug profiles, including clinical and no ... Read More

• Lyme Disease - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Lyme Disease - Pipeline Insight, 2024 DelveInsight’s, “Lyme Disease - Pipeline Insight, 2024,” report provides comprehensive insights about 7+ companies and 7+ pipeline drugs in Lyme Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. ... Read More

• Non-Radiographic Axial Spondyloarthritis (nrAxSpA) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Non-Radiographic Axial Spondyloarthritis (nrAxSpA) - Pipeline Insight, 2024 Non-Radiographic Axial Spondyloarthritis (nrAxSpA) Overview ""Non-Radiographic Axial Spondyloarthritis (nrAxSpA) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development ... Read More

• Autoimmune pulmonary alveolar proteinosis (aPAP) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Autoimmune pulmonary alveolar proteinosis (aPAP) - Pipeline Insight, 2024 Autoimmune pulmonary alveolar proteinosis (aPAP) Overview ""Autoimmune pulmonary alveolar proteinosis (aPAP) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenar ... Read More

• Autoimmune Encephalitis (AE) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Autoimmune Encephalitis (AE) - Pipeline Insight, 2024 Autoimmune Encephalitis (AE) Overview ""Autoimmune Encephalitis (AE) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Autoimmune Encephalitis ( ... Read More

• Bladder Pain - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Bladder Pain - Pipeline Insight, 2024 Bladder Pain Overview ""Bladder Pain Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Bladder Pain market. A detailed picture of the Bladder Pain pipeline land ... Read More

• Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) - Pipeline Insight, 2024 Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Overview ""Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical developme ... Read More

• Chronic Hepatitis C Virus Infection - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Chronic Hepatitis C Virus Infection - Pipeline Insight, 2024 DelveInsight’s, “Chronic Hepatitis C Virus Infection - Pipeline Insight, 2024,” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Chronic Hepatitis C Virus Infection pipeline landscape. It covers the pipel ... Read More

• Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2024 DelveInsight’s, “Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2024,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Chronic Hepatitis Delta Virus (HDV) Infection pipeline ... Read More

• Adrenocortical Carcinoma - Market Insight, Epidemiology And Market Forecast - 2034

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Adrenocortical Carcinoma - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Attributed to the rising diagnosed prevalent cases and increasing awareness, the Molybdenum Cofactor Deficiency Type A (MoCoD-A) market was valued at nearly USD 12 million in 2023 and is expected to exp ... Read More

• Sjogren's Syndrome - Market Insight, Epidemiology And Market Forecast - 2034

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Sjogren's Syndrome - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The prevalence of pulmonary arterial hypertension has been increasing due to the rising frequency of cardiovascular diseases and arterial hypertension. Furthermore, the growing adult population, which is more ... Read More

• Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2024 DelveInsight’s, “Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insight, 2024” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Anaplastic Lymphoma Kinase (ALK) Inhibitors pipeline landscape. I ... Read More

• Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer - Pipeline Insight, 2024 DelveInsight’s, “Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer - Pipeline Insight, 2024,” report provides comprehensive insights about 3+ companies and 3+ pipeline ... Read More

• Chronic Back Pain - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Chronic Back Pain - Pipeline Insight, 2024 Chronic Back Pain Overview ""Chronic Back Pain Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Chronic Back Pain market. A detailed picture of the Chroni ... Read More

• Sciatic Pain - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Sciatic Pain - Pipeline Insight, 2024 Sciatic Pain Overview ""Sciatic Pain Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Sciatic Pain market. A detailed picture of the Sciatic Pain pipeline land ... Read More

• Metastatic Bone Pain - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Metastatic Bone Pain - Pipeline Insight, 2024 DelveInsight’s, “Metastatic Bone Pain – Pipeline Insight, 2024,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Metastatic Bone Pain pipeline landscape. It covers the pipeline drug profiles, including clinical and no ... Read More

• Complex Regional Pain Syndrome - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Complex Regional Pain Syndrome - Pipeline Insight, 2024 Complex Regional Pain Syndrome Overview ""Complex Regional Pain Syndrome Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Complex Regional Pa ... Read More

• Neuropathic Pain - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Neuropathic Pain - Pipeline Insight, 2024 Neuropathic Pain Overview ""Neuropathic Pain Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Neuropathic Pain market. A detailed picture of the Neuropathi ... Read More

< prev 10 11 12 13 14 15 16 17 18 19 next >